US FDA wants reusable device makers to validate reprocessing instructions
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued final guidance to help manufacturers of reusable medical devices develop safer products, especially those that pose a greater risk of infection1-3.
You may also be interested in...
Endoscope Final Guidance Calls For Backflow Prevention
Irrigation accessories used with endoscopes pose a risk of cross-contamination when used on multiple patients. An FDA final guidance will require these devices to include a backflow-prevention valve to mitigate the risk.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.